Fulminant hepatitis.
University of Toronto, Canada.
S
S
Sinclair
A
A
Wakefield
G
G
Levy
D001778:Blood Coagulation Disorders / Q000209:etiology; D006509:Hepatitis B / Q000150:complications / Q000276:immunology* / Q000628:therapy; D006510:Hepatitis B Antibodies / Q000096:biosynthesis; D006515:Hepatitis B virus / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007372:Interferons / Q000502:physiology; D011453:Prostaglandins / Q000502:physiology
D006510:Hepatitis B Antibodies; D011453:Prostaglandins; D007372:Interferons